G A Losonsky Selected Research

respiratory syncytial virus immune globulin intravenous

1/2008

Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G A Losonsky Research Topics

Disease

2	Pain (Aches) 02/2001 - 01/2000
2	Tetanus 05/2000 - 01/2000
2	Diphtheria 05/2000 - 01/2000
2	Whooping Cough (Pertussis) 05/2000 - 01/2000
1	Respiratory Syncytial Virus Infections 01/2008
1	Virus Diseases (Viral Diseases) 01/2008
1	Asymptomatic Infections 06/2001
1	Colitis 02/2001
1	Infections 02/2001

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 06/2001 - 01/2000
1	motavizumab (Numax)IBA 01/2008
1	AntibodiesIBA 01/2008
1	GlobulinsIBA 01/2008
1	respiratory syncytial virus immune globulin intravenousIBA 01/2008
1	Palivizumab FDA Link 01/2008
1	aluminum sulfate (alum)IBA 02/2001
1	ToxoidsIBA 02/2001
1	Phosphates (Orthophosphate)IBA 05/2000
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2000
1	AluminumIBA 01/2000
1	Diphtheria-Tetanus-acellular Pertussis Vaccines (Tripedia)FDA Link 01/2000
1	Pertussis ToxinIBA 01/2000
1	pertussis toxoidIBA 01/2000

Therapy/Procedure

1	Therapeutics 02/2001